162 related articles for article (PubMed ID: 23752311)
1. Meganuclease-mediated virus self-cleavage facilitates tumor-specific virus replication.
Gürlevik E; Schache P; Goez A; Kloos A; Woller N; Armbrecht N; Manns MP; Kubicka S; Kühnel F
Mol Ther; 2013 Sep; 21(9):1738-48. PubMed ID: 23752311
[TBL] [Abstract][Full Text] [Related]
2. Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.
Doloff JC; Jounaidi Y; Waxman DJ
Cancer Gene Ther; 2011 Mar; 18(3):153-66. PubMed ID: 20865021
[TBL] [Abstract][Full Text] [Related]
3. A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication.
Fechner H; Wang X; Picó AH; Wildner J; Suckau L; Pinkert S; Sipo I; Weger S; Poller W
J Biotechnol; 2007 Jan; 127(4):560-74. PubMed ID: 17083991
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral E1a expression levels affect virus-selective replication in human cancer cells.
Zheng X; Rao XM; Snodgrass C; Wang M; Dong Y; McMasters KM; Zhou HS
Cancer Biol Ther; 2005 Nov; 4(11):1255-62. PubMed ID: 16222119
[TBL] [Abstract][Full Text] [Related]
5. Optimization of an E1A Gene Expression Cassette in an Oncolytic Adenovirus for Efficient Tumor Cell Killing Activity.
Sakurai F; Nishimae F; Takayama K; Mizuguchi H
Anticancer Res; 2021 Feb; 41(2):773-782. PubMed ID: 33517282
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication.
Gürlevik E; Woller N; Schache P; Malek NP; Wirth TC; Zender L; Manns MP; Kubicka S; Kühnel F
Nucleic Acids Res; 2009 Jul; 37(12):e84. PubMed ID: 19443444
[TBL] [Abstract][Full Text] [Related]
7. Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy.
Cherry T; Longo SL; Tovar-Spinoza Z; Post DE
Gene Ther; 2010 Dec; 17(12):1430-41. PubMed ID: 20664541
[TBL] [Abstract][Full Text] [Related]
8. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
9. Artificial riboswitches for gene expression and replication control of DNA and RNA viruses.
Ketzer P; Kaufmann JK; Engelhardt S; Bossow S; von Kalle C; Hartig JS; Ungerechts G; Nettelbeck DM
Proc Natl Acad Sci U S A; 2014 Feb; 111(5):E554-62. PubMed ID: 24449891
[TBL] [Abstract][Full Text] [Related]
10. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
11. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
12. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
13. Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery.
Kwon OJ; Kang E; Kim S; Yun CO
J Control Release; 2011 Oct; 155(2):317-25. PubMed ID: 21699929
[TBL] [Abstract][Full Text] [Related]
14. Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.
Höti N; Chowdhury WH; Mustafa S; Ribas J; Castanares M; Johnson T; Liu M; Lupold SE; Rodriguez R
Cancer Gene Ther; 2010 Aug; 17(8):585-97. PubMed ID: 20448671
[TBL] [Abstract][Full Text] [Related]
15. [Quality control of recombinant oncolytic adenovirus/p53].
Gao K; Bi H; Ding YX; Li YH; Han CM; Guo Y; Rao CM
Yao Xue Xue Bao; 2011 Dec; 46(12):1476-82. PubMed ID: 22375422
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.
Watanabe Y; Hashimoto Y; Kagawa S; Kawamura H; Nagai K; Tanaka N; Urata Y; Fujiwara T
Cancer Gene Ther; 2012 Nov; 19(11):767-72. PubMed ID: 22956040
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.
Wang F; Wang Z; Tian H; Qi M; Zhai Z; Li S; Li R; Zhang H; Wang W; Fu S; Lu J; Rodriguez R; Guo Y; Zhou L
Curr Gene Ther; 2012 Apr; 12(2):67-76. PubMed ID: 22384806
[TBL] [Abstract][Full Text] [Related]
18. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
Xu HN; Huang WD; Cai Y; Ding M; Gu JF; Wei N; Sun LY; Cao X; Li HG; Zhang KJ; Liu XR; Liu XY
Mol Cancer; 2011 Nov; 10():133. PubMed ID: 22040050
[TBL] [Abstract][Full Text] [Related]
19. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
Bilsland AE; Merron A; Vassaux G; Keith WN
Cancer Res; 2007 Feb; 67(3):1299-307. PubMed ID: 17283167
[TBL] [Abstract][Full Text] [Related]
20. Construction of a recombinant adenovirus for efficient delivery of the I-SceI yeast endonuclease to human cells and its application in the in vivo cleavage of chromosomes to expose new potential telomeres.
Anglana M; Bacchetti S
Nucleic Acids Res; 1999 Nov; 27(21):4276-81. PubMed ID: 10518621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
